roche glp-1 Roche's head of cardiovascular disease dissects drug trial results Roche unveils new obesity drug
Description
Single-use pens like Wegovy and Trulicity are discarded immediately after injection
These numbers are vital for understanding your risk of heart disease
Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity PNAS
Eat Smaller, More Frequent Meals Experts advise that eating smaller, more frequent meals rather than two big meals a day can help reduce the gastrointestinal side effects of Ozempic (semaglutide)
Notify your healthcare provider if you notice any changes in your vision while taking Zepbound
Category-level regulatory research: Published legal analyses from law firms including Epstein Becker Green, Orrick, Crowell & Moring, Pharmacy Times, and Drug Topics, used to contextualize the 503B regulatory environment
